Clinical Trial Details
| Trial ID: | L2021 |
| Source ID: | NCT00676260 |
| Associated Drug: | Pioglitazone |
| Title: | Efficacy of Pioglitazone on Microcirculation in Type 2 Diabetes Patients Treated With Insulin |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes Mellitus |
| Interventions: | DRUG: Pioglitazone|DRUG: Placebo |
| Outcome Measures: | Primary: Capillary filtration capacity., Final Visit | Secondary: Isovolumetric venous pressure., Final Visit|Capillary pressure., Final Visit|Postural vasoconstriction., Final Visit|Maximum blood flow., Final Visit|Capillary recruitment., Final Visit|24-hour ambulatory blood pressure., Final Visit|Interleukin-6, Final Visit|C-Reactive Protein., Final Visit|Vascular Endothelium Growth Factor., Final Visit |
| Sponsor/Collaborators: | Sponsor: Takeda |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE2 |
| Enrollment: | 29 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT |
| Start Date: | 2002-12 |
| Completion Date: | 2004-08 |
| Results First Posted: | |
| Last Update Posted: | 2012-02-28 |
| Locations: | Exeter, United Kingdom |
| URL: | https://clinicaltrials.gov/show/NCT00676260 |
